Biomaterial Database

Nuclear magnetic resonance analysis of pharmaceuticals. Part XV. Determination of sulfamethoxazole and trimethoprim in combination in tablets. 1977

J W Turczan

UI	MeSH Term	Description	Entries
D009682	Magnetic Resonance Spectroscopy	Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).	In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004338	Drug Combinations	Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.	Drug Combination,Combination, Drug,Combinations, Drug
D013420	Sulfamethoxazole	A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)	Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D013607	Tablets	Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)	Tablet
D014295	Trimethoprim	A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.	Proloprim,Trimpex

Related Publications

J W Turczan

[Densitometric determination of trimethoprim and sulfamethoxazole in tablets].

December 1980, Die Pharmazie,

J W Turczan

NMR determination of trimethoprim and sulfamethoxazole in tablets and powders.

January 1977, Journal of pharmaceutical sciences,

J W Turczan

Determination of phenylbutazone in tablets by nuclear magnetic resonance spectrometry.

November 1984, Journal of pharmaceutical sciences,

J W Turczan

Rapid colorimetric assay of trimethoprim and sulfamethoxazole in pharmaceuticals.

November 1983, Journal - Association of Official Analytical Chemists,

J W Turczan

[Acute myopia and combination sulfamethoxazole-trimethoprim].

January 1989, Journal de toxicologie clinique et experimentale,

J W Turczan

[The combination sulfamethoxazole-trimethoprim in vitro].

September 1972, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,

J W Turczan

Quantitative determination of some pharmaceuticals in bulk drugs and tablets by proton magnetic resonance (PMR) spectroscopy.

April 1990, Farmaco (Societa chimica italiana : 1989),

J W Turczan

[Studies of combination trimethoprim-sulfamethoxazole in urology].

January 1971, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,

J W Turczan

Determination of apomorphine freebase in sublingual tablets by proton nuclear magnetic resonance spectroscopy.

September 2016, Journal of pharmaceutical and biomedical analysis,

J W Turczan

[Experimentation with the sulfamethoxazole-trimethoprim combination].

October 1972, Bordeaux medical,